Want to see IN:BROOKS full AI Analyst Report?
Total Valuation
Brooks Laboratories Limited has a market cap or net worth of ₹1.80B. The enterprise value is ₹1.98B.
Market Cap₹1.80B
Enterprise Value₹1.98B
Share Statistics
Brooks Laboratories Limited has 29,457,249 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,457,249
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Brooks Laboratories Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 4.12%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)4.12%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee2.65M
Profits Per Employee761.10K
Employee Count323
Asset Turnover0.58
Inventory Turnover6.15
Valuation Ratios
The current PE Ratio of Brooks Laboratories Limited is 7.3. Brooks Laboratories Limited’s PEG ratio is -0.01.
PE Ratio7.3
PS Ratio1.27
PB Ratio0.89
Price to Fair Value0.89
Price to FCF21.48
Price to Operating Cash Flow559.18
PEG Ratio-0.01
Income Statement
In the last 12 months, Brooks Laboratories Limited had revenue of 857.38M and earned 245.84M in profits. Earnings per share was 8.35.
Revenue857.38M
Gross Profit179.65M
Operating Income54.70M
Pretax Income245.84M
Net Income245.84M
EBITDA270.09M
Earnings Per Share (EPS)8.35
Cash Flow
In the last 12 months, operating cash flow was 3.19M and capital expenditures -7.03M, giving a free cash flow of -3.84M billion.
Operating Cash Flow3.19M
Free Cash Flow-3.84M
Free Cash Flow per Share-0.13
Dividends & Yields
Brooks Laboratories Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change-61.25%
50-Day Moving Average67.31
200-Day Moving Average76.34
Relative Strength Index (RSI)38.58
Average Volume (3m)2.20K
Important Dates
Brooks Laboratories Limited upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 29, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Brooks Laboratories Limited as a current ratio of 1.72, with Debt / Equity ratio of 6.94%
Current Ratio1.72
Quick Ratio1.21
Debt to Market Cap0.07
Net Debt to EBITDA0.04
Interest Coverage Ratio6.55
Taxes
In the past 12 months, Brooks Laboratories Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Brooks Laboratories Limited EV to EBITDA ratio is 4.08, with an EV/FCF ratio of 21.67.
EV to Sales1.29
EV to EBITDA4.08
EV to Free Cash Flow21.67
EV to Operating Cash Flow12.83
Balance Sheet
Brooks Laboratories Limited has ₹75.49M in cash and marketable securities with ₹85.17M in debt, giving a net cash position of -₹9.68M billion.
Cash & Marketable Securities₹75.49M
Total Debt₹85.17M
Net Cash-₹9.68M
Net Cash Per Share-₹0.33
Tangible Book Value Per Share₹41.66
Margins
Gross margin is 30.73%, with operating margin of 6.38%, and net profit margin of 28.67%.
Gross Margin30.73%
Operating Margin6.38%
Pretax Margin28.67%
Net Profit Margin28.67%
EBITDA Margin31.50%
EBIT Margin29.65%
Analyst Forecast
The average price target for Brooks Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.85%
EPS Growth Forecast―